Lactulose
Duphalac Fruit, Lactulose Genericon, Lactulose Hexal, Lactulose Mip · ATC code A06AD11
Also known as: Β-Lactulose, Laktuloz · Brand names: Duphalac Fruit, Lactulose Genericon, Lactulose Hexal, Lactulose Mip, Bifiteral, Lactuflor, Lactulade, Duphalac, Hepalac, Lacselac, Lactozen, Lactulac, Laevolac, Laktilit, Laxamot …
- Key facts
- Active substance
- Lactulose
- Drug class
- Hyperosmotic laxative
- ATC code
- A06AD11
- Authorisation
- authorised nationally; no central EU authorisation
- Information as of
- 2026-10-29
Key facts
Lactulose is, per the US prescribing information, a poorly absorbed sugar (disaccharide) that is broken down by colonic bacteria and is used to treat constipation.
What it is used for
- Treatment of constipation.
- In chronic constipation, lactulose solution increases the number of bowel movements per day and the number of days with bowel movements.
Dosing
- Usual dose: 1 to 2 tablespoonfuls (15 to 30 mL, containing 10 g to 20 g of lactulose) daily.
- May be increased to 60 mL daily if necessary.
- 24 to 48 hours may be needed to produce a normal bowel movement, as it acts only once it reaches the colon.
- The solution may be mixed with fruit juice, water or milk.
Contraindications
- Patients who require a low galactose diet (the solution contains galactose).
Important warnings
- During electrocautery at proctoscopy or colonoscopy there is a theoretical risk of an explosive reaction from accumulated hydrogen gas; thorough bowel cleansing with a non-fermentable solution is advised.
- Use with caution in diabetics, as the solution contains galactose and lactose.
- Elderly, debilitated patients treated for more than six months should have serum electrolytes (potassium, chloride, carbon dioxide) measured periodically.
- Patients should contact a physician if an unusual diarrheal condition occurs.
Side effects
- Precise frequency data are not available.
- Initial flatulence and intestinal cramps, usually transient.
- Excessive dosage can lead to diarrhea with loss of fluids, hypokalemia and hypernatremia.
- Nausea and vomiting have been reported.
Interactions
- Non-absorbable antacids may inhibit the desired drop in colonic pH and reduce the effect.
Pregnancy and breastfeeding
- Animal studies showed no evidence of harm to the fetus; there are no adequate studies in pregnant women.
- It is not known whether lactulose is excreted in human milk; use caution in nursing women.
Summary of the official product information, written with AI on 2026-10-29. Every number was checked automatically against the original text. Not reviewed by a physician – the full official text is authoritative.
Common questions – ask Medelix
For patients
Patient information (US)
This product has no separate US patient information.
Authorisation and brand names by country
Medicines with exactly this active-substance composition, as listed in the national registers – alphabetical and without ranking. Whether a product is currently available is not shown here.
Austria
- Duphalac FruitCooper Consumer Health B.V. · 1 register entry
- Lactulose GenericonGenericon Pharma Gesellschaft M.B.H. · 1 register entry
- Lactulose HexalHexal Pharma Gmbh · 1 register entry
- Lactulose MipMip Pharma Austria Gmbh · 1 register entry
Source: EMA – Article 57 product data (EU/EEA), as of 2026-10-29
Germany
- BifiteralCooper Consumer Health Deutschland Gmbh, Cooper Consumer Health B.V. · 2 register entries
- LactuflorMip Pharma Gmbh · 1 register entry
- LactuladeCnp Pharma Gmbh · 1 register entry
- Lactulose1 A Pharma Gmbh, T&d Pharma Gmbh, Ratiopharm Gmbh, Heumann Pharma Gmbh & Co. Generica Kg, Hexal Ag, Stada Consumer Health Deutschland Gmbh, Chephasaar Chemisch-Pharmazeutische Fabrik Gmbh, Abz-Pharma Gmbh, Aliud Pharma Gmbh · 10 register entries
Source: EMA – Article 57 product data (EU/EEA), as of 2026-10-29
Turkey
- DuphalacABBOTT LABORATUARLARI İTHALAT İHRACAT VE TİC. LTD. ŞTİ. · 2 register entries
- HepalacSANOVEL İLAÇ SAN. VE TİC. A.Ş. · 1 register entry
- LacselacTEBEM İLAÇ SAN. TUR. VE TİC. A.Ş. · 1 register entry
- LactozenDR. SERTUS İLAÇ SAN. VE TİC. LTD. ŞTİ. · 1 register entry
- LactulacKOÇAK FARMA İLAÇ VE KİMYA SAN. A.Ş. · 3 register entries
- LaevolacMENARİNİ SAĞLIK VE İLAÇ SAN. TİC. A.Ş. · 2 register entries
- LaktilitBERKO İLAÇ VE KİMYA SAN. A.Ş. · 4 register entries
- LaxamotBERAT BERAN İLAÇ SAN. VE TİC. LTD. ŞTİ. · 4 register entries
- Medulac WMWORLD MEDICINE İLAÇ SAN. VE TİC. A.Ş. · 1 register entry
- OralacŞİFA KİMYA İLAÇ KOZMETİK SANAYİ VE TİC. A.Ş. · 4 register entries
- OsmalakBİOFARMA İLAÇ SAN. VE TİC. A.Ş. · 1 register entry
- RexlacMCG PHARMA İLAÇ SAN. VE TİC. LTD. ŞTİ. · 1 register entry
Show all 14 brand names
- TulozLİBA LABORATUARLARI A.Ş. · 1 register entry
- ZubeyraWORLD MEDICINE OPHTHALMICS İLAÇLARI LTD. ŞTİ. · 1 register entry
Source: TİTCK – Ruhsatlı Beşeri Tıbbi Ürünler Listesi, as of 2026-10-16
USA
- ConstuloseActavis Pharma, Inc. · 1 register entry
- EnuloseActavis Pharma, Inc. · 2 register entries
- GenerlacChartwell RX, LLC · 1 register entry
- KristaloseCumberland Pharmaceuticals Inc. · 1 register entry
Source: U.S. FDA – Drug labels (openFDA/DailyMed), as of 2026-10-29
Brand names in 26 more European countries
- Belgium
- Bifiteral, Duphalac, Lactulose Eg
- Bulgaria
- Дуфалак, Лактулакс, Лактулоза Mip, Лактус, Медулак-Вм
- Croatia
- Portalak
- Cyprus
- Duphalac
- Czechia
- Duphalac, Lactulosa Biomedica, Lactulose Al
- Denmark
- Lactulose Orifarm, Medilax
- Estonia
- Duphalac, Lactulose Mip
- Finland
- Duphalac, Lactulos Ratiopharm, Laktufarm, Levolac
- France
- Duphalac, Lactulose Arrow, Lactulose Biogaran, Lactulose Cooper, Lactulose Sandoz, Lactulose Viatris, Lactulose Zentiva
- Greece
- Duphafruit, Duphalac
- Iceland
- Medilax
- Ireland
- Brillphalac, Lactecon, Laxose
- Italy
- Duphalac, Epalfen Eps, Laevolac, Lattulac, Lattulosio Abc, Lattulosio Almus, Lattulosio Alter, Lattulosio Aurobindo, Lattulosio Cooper, Lattulosio Eg, Lattulosio Pensa, Lattulosio Sandoz, Lattulosio Teva, Lattulosio Zentiva, Normase
- Latvia
- Duphalac Fruit, Lactulose Mip
- Lithuania
- Duphalac, Lactulose Mip
- Luxembourg
- Bifiteral, Duphalac, Lactulose Eg, Lactulose Ratiopharm
- Malta
- Duphalac, Lactulose
- Netherlands
- Duphalac, Lactulose Aurobindo, Lactulose Cch, Lactulose Greenwood, Lactulose Leidapharm, Lactulose Marel, Lactulose Sam, Lactulose Sandoz, Lactulosestroop Albert Heijn, Laxeerdrank, Laxeersiroop
- Norway
- Duphalac
- Poland
- Duphalac, Lactulose Mip, Lactulosum Espefa, Lactulosum Forte Orifarm, Lactulosum Forte Polfarmex, Lactulosum Orifarm, Lactulosum Polfarmex, Normalac
- Portugal
- Duphalac, Lactulose Farmoz, Lactulose Generis, Lactulose Novalie, Lactulose Sandoz, Laevolac, Perphyl, Solax
- Romania
- Duphalac Fruit, Lactecon, Lactulose Eipico, Lactulose Mip
- Slovakia
- Duphalac, Lactecon, Lactulosa Biomedica
- Slovenia
- Prorektal
- Spain
- Duphalac, Lactulosa Lainco, Lactulosa Level
- Sweden
- Duphalac, Laktulos Cooper
EMA – Article 57 product data (EU/EEA), 2026-10-29
Medelix receives no money from pharmaceutical companies. Brand names are listed alphabetically and without ranking.
Another question about this substance?
Medelix answers clinical questions from guidelines, studies and product information – every claim with its source.
Sources
- U.S. Food and Drug Administration. Lactulose (APOZEAL PHARMACEUTICALS INC) – Prescribing Information, 2026-07-23. DailyMed (NLM), 2026-10-29. https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=72ac130a-de85-464d-9e9b-05cac0c54db1
- EMA – Article 57 product data (EU/EEA), 2026-10-29. https://www.ema.europa.eu/en/human-regulatory-overview/post-authorisation/data-medicines-iso-idmp-standards-post-authorisation/public-data-article-57-database
- EMA – Article 57 product data (EU/EEA), 2026-10-29. https://www.ema.europa.eu/en/human-regulatory-overview/post-authorisation/data-medicines-iso-idmp-standards-post-authorisation/public-data-article-57-database
- TİTCK – Ruhsatlı Beşeri Tıbbi Ürünler Listesi, 2026-10-16. https://www.titck.gov.tr/dinamikmodul/85
- U.S. FDA – Drug labels (openFDA/DailyMed), 2026-10-29. https://dailymed.nlm.nih.gov/dailymed/
- Wikidata (CC0): ATC A06AD.
Editorial: Medelix editorial team · last updated 2026-10-29 · How these pages are made · Report an error
Source: U.S. Food and Drug Administration (FDA), prescribing information, via DailyMed (NLM); public domain. Not advertising, not a treatment recommendation. For questions about your own treatment, ask your doctor or pharmacist.